Berkshire Asset Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Berkshire Asset Management’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-153,810	Closed	-$692K	–	288
2025 Q1	$692K	Buy	+153,810	New	+$638K	0.03%	163
2022 Q3	–	Sell	-189,048	Closed	-$392K	–	220
2022 Q2	$392K	Buy	189,048 +6,907	+4%	+$16K	0.03%	159
2022 Q1	$514K	Hold	182,141	–	–	0.03%	137
2021 Q4	$851K	Buy	182,141 +5,956	+3%	+$20.3K	0.05%	128
2021 Q3	$472K	Buy	176,185 +5,355	+3%	+$15.9K	0.03%	169
2021 Q2	$486K	Buy	170,830 +5,335	+3%	+$15.7K	0.03%	160
2021 Q1	$501K	Hold	165,495	–	–	0.04%	151
2020 Q4	$488K	Buy	+165,495	New	+$501K	0.04%	148
2020 Q2	–	Sell	-164,495	Closed	-$597K	–	177
2020 Q1	$597K	Buy	+164,495	New	+$736K	0.06%	120
2013 Q4	–	Sell	-28,100	Closed	-$127K	–	169
2013 Q3	$127K	Sell	28,100 -900	-3%	-$4.48K	0.03%	137
2013 Q2	$148K	Buy	+29,000	New	+$144K	0.04%	119

Other funds holding CPIX

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Berkshire Asset Management's CPIX Position: Q2 2025 in Review

Berkshire Asset Management sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2025, closing a stake of 153,810 shares — an estimated $692K sold.

Berkshire Asset Management first reported a position in CPIX in Q2 2013 and held it in 11 quarters. The position peaked at $851K in Q4 2021. 31 funds tracked by Wall St. Rank hold CPIX as of Q2 2025.

Berkshire Asset Management reported no remaining Cumberland Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Berkshire Asset Management sold 153,810 Cumberland Pharmaceuticals shares in Q2 2025, an estimated $692K.
Berkshire Asset Management first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 11 quarters.
Berkshire Asset Management's Cumberland Pharmaceuticals position peaked at $851K in Q4 2021.
31 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2025.

Based on Berkshire Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.